AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) sold $15K-$50K of AbbVie Inc. (ABBV) stock
David Perdue, U.S. Senator (R-GA), disclosed a sale of AbbVie Inc. (ABBV) stock worth $15K-$50K in a STOCK Act filing on Aug 5, 2019.
The trade happened on Jul 15, 2019, 21 days before it was made public.
ABBV has moved +274.1% since the trade date, from $70.27 to $262.90 (Oct 2, 2026 close).
- Traded
- Jul 15, 2019
- Disclosed
- Aug 5, 2019
- Filing delay
- 21 days
- Price since
- +274.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (35)
- BuyBMY$15K-$50KAug 5, 2019
- SellBWXT$15K-$50KAug 5, 2019
- BuyDOW$15K-$50KAug 5, 2019
- BuyDOW$15K-$50KAug 5, 2019
- BuyKR$15K-$50KAug 5, 2019
- SellBWXT$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellCZR$1K-$15KAug 5, 2019
- SellDD$1K-$15KAug 5, 2019
- SellDD$1K-$15KAug 5, 2019
- BuyENTG$1K-$15KAug 5, 2019
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.